PHA-793887

DB12686InvestigationalSmall molecule

PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.

Chemical structure of PHA-793887
Mechanism
Curator reviewed
Formula / weight
C19H31N5O2 · 361.4817 g/mol (avg)
Code names
PHA-793887

Resolves to

Compound
UNIIMKS45S912BCAS718630-59-2ChEMBLCHEMBL1230607ChEBI91371PubChem46191454
Structure
InChIKeyHUXYBQXJVXOMKX-UHFFFAOYSA-NSMILESCC(C)CC(=O)NC1=NNC2=C1CN(C(=O)C1CCN(C)CC1)C2(C)C
Targets
P06493CDK1P11802CDK4P24941CDK2

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PHA-793887, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In